Guidance issued for optimal timing of knee, hip total joint arthroplasty
For patients with symptomatic, radiographic, moderate-to-severe osteoarthritis or osteonecrosis of the hip or knee, total joint arthroplasty (TJA) should not be delayed in order to pursue additional nonoperative treatments, according to a clinical practice guideline issued by the American College of Rheumatology and the American Association of Hip and Knee Surgeons.
Patients aged 75 years and older report better pain relief than younger patients
All patients undergoing total knee arthroplasty (TKA) have improvement in outcomes; however, patients aged 75 years and older (late elders) achieve better pain relief and improved quality of life compared with younger patients (younger than 55 years), according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 7 to 11 in Las Vegas.
Short term outcomes (average follow up of 2.4 years) of a constrained acetabular liner in primary and revision total hip arthroplasty.
As instability continues to be a burden post total hip arthroplasty (THA), there has been a controversial discussion on the ideal implant choice. We report here the outcomes of a modern constrained acetabular liner (CAL) system in primary and revision THA at an average follow up of 2.4 years.
Patients With Knee Osteoarthritis Who Receive Platelet-Rich Plasma or Bone-Marrow Aspirate Concentrate Injections Have Better Outcomes Than Patients Who Receive Hyaluronic Acid: Systematic Review and Meta-analysis
To systematically review the literature in order to compare the efficacy and safety of platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and hyaluronic acid (HA) injections for the treatment of knee osteoarthritis (OA).
Implant survivorship 99 percent for young hip arthroplasty patients
Patients younger than 65 years undergoing total hip arthroplasty (THA) have 99 percent implant survivorship at eight years and have low rates of revision and readmission, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 7 to 11 in Las Vegas.
